AIIMS Bhopal study flags hidden heart, kidney risks in sickle cell kids
Synopsis
An AIIMS Bhopal study has found that nearly 71% of children with sickle cell disease show signs of early vascular injury even when routine blood pressure tests appear normal. Hidden cardiac, kidney, and sleep complications — detectable only through advanced tools like ABPM and cystatin C testing — are going undiagnosed, raising urgent questions about the adequacy of standard care protocols for SCD patients in Madhya Pradesh's tribal regions.
Key Takeaways
AIIMS Bhopal published a sickle cell disease study in the journal International Pediatric Nephrology , led by Dr.
Harshitha S. under Dr.
Girish Chandra Bhatt .
Nearly 71% of children studied showed early cardiovascular or vascular injury despite normal blood pressure in routine check-ups.
24-hour ambulatory blood pressure monitoring (ABPM) revealed hidden blood pressure abnormalities, including elevated pressure during sleep.
Obstructive sleep apnea (OSA) was found to be common among children with sickle cell disease, raising cardiac risk.
Kidney marker cystatin C detected reduced renal function in cases where conventional tests returned normal results.
The findings are particularly significant for Madhya Pradesh , where SCD heavily affects tribal populations.
A study by the All India Institute of Medical Sciences (AIIMS) Bhopal has called for early and advanced health screening in children with sickle cell disease (SCD), after researchers identified concealed cardiac, renal, and sleep-related complications that routine tests routinely miss. The findings, published in the journal International Pediatric Nephrology, carry particular weight for Madhya Pradesh, where SCD disproportionately burdens tribal communities.
About the Research
The study was conducted by the Department of Pediatrics's Division of Pediatric Nephrology and Hypertension at AIIMS Bhopal. Dr. Harshitha S. led the research under the supervision of Dr. Girish Chandra Bhatt. The team examined the effects of sickle cell disease on blood pressure, sleep quality, cardiac health, and kidney function across a paediatric cohort.
Key Findings: Hidden Complications
Doctors deployed 24-hour ambulatory blood pressure monitoring (ABPM) — a tool not used in standard check-ups — and uncovered blood pressure abnormalities in several patients, including elevated pressure during sleep that would have gone undetected in routine hospital visits. Separately, the study found that obstructive sleep apnea (OSA) was prevalent among the children studied; researchers noted that those with sleep apnea faced a heightened risk of damage to blood vessels and the heart.
Critically, nearly 71 per cent of the children showed signs of early cardiovascular or vascular injury even when blood pressure readings appeared normal during standard consultations. This underscores a significant diagnostic gap in current care protocols.
Kidney Damage Detected Early
The research also surfaced early-stage kidney complications. Proteinuria — an established early marker of kidney damage — was detected in a substantial number of children. More sensitive renal assessments using cystatin C identified reduced kidney function in a significant share of patients, in cases where conventional tests had returned normal results. The findings suggest that standard kidney tests may be inadequate for this patient population.
What the Doctors Said
Dr. Girish Chandra Bhatt said the study underlines the imperative for comprehensive care. 'These findings show that children with sickle cell disease require regular screening beyond routine blood tests. Early detection of hidden heart, kidney and sleep-related complications can help improve treatment and long-term outcomes,' he said.
Implications for Madhya Pradesh and Beyond
Sickle cell disease is endemic across several tribal districts of Madhya Pradesh, making the study's recommendations especially urgent for the state's public health infrastructure. Researchers believe the findings will help clinicians develop more targeted screening and treatment strategies, potentially reducing the long-term organ damage associated with SCD. The study's publication in an international peer-reviewed journal is expected to inform protocols beyond India as well.
Point of View
The absence of ABPM and cystatin C testing in district hospitals is not a clinical oversight but a resource and policy failure. The study's real ask is not just of doctors — it is of health administrators who set protocol standards.
NationPress
11 Jul 2026
Frequently Asked Questions
What did the AIIMS Bhopal sickle cell disease study find?
The study found that a large proportion of children with sickle cell disease had hidden heart, kidney, and sleep-related complications that routine medical tests failed to detect. Nearly 71% showed signs of early cardiovascular or vascular injury even when standard blood pressure readings appeared normal.
What is sickle cell disease and why is it a concern in Madhya Pradesh?
Sickle cell disease is an inherited blood disorder in which red blood cells take an abnormal, crescent shape, impairing oxygen delivery and damaging organs over time. It is particularly prevalent in tribal communities across Madhya Pradesh, making the state one of the most affected regions in India.
What advanced tests did researchers use in the study?
Researchers used 24-hour ambulatory blood pressure monitoring (ABPM) to detect hidden blood pressure abnormalities and cystatin C-based kidney tests to identify reduced renal function that conventional tests missed. These tools are not part of standard paediatric check-up protocols.
What is obstructive sleep apnea and how does it affect sickle cell children?
Obstructive sleep apnea (OSA) is a condition in which breathing repeatedly stops and starts during sleep. The study found OSA to be common among children with sickle cell disease, and researchers noted that affected children faced a greater risk of blood vessel and cardiac damage.
What are the implications of the study for treatment?
The researchers believe the findings will prompt clinicians to adopt more comprehensive screening protocols — including ABPM and cystatin C testing — for children with sickle cell disease, enabling earlier intervention and potentially reducing long-term organ complications.
